Una historia resumida. Impacto de los avances en el control lipídico

Cholesterol is a key modifiable risk factor for the development of atherosclerosis. Numerous studies have shown that statins can reduce plasma cholesterol levels and decrease the development of atherosclerotic complications, both in primary and secondary prevention. In fact, clinical practice guidelines recommend the use of statins as essential drugs in the control of hypercholesterolaemia, recommending stricter levels of low-density lipoprotein cholesterol in patients at high cardiovascular risk and in secondary prevention. Despite this, numerous patients are not adequately controlled, which is due to various factors depending on the drugs, the doctor and the patients. Therefore, there is a substantial margin for improvement in the degree of control of patients with hypercholesterolaemia.